Cook Medical's Zenith Alpha Approved and Launched in Canada

December 10, 2015—Cook Medical announced the commercial launch of the Zenith Alpha abdominal endovascular graft in Canada, where it recently received Canadian approval. The first patient was treated with the device at the University of Western London Health Sciences Center in London, Ontario.

Zenith Alpha abdominal is indicated for endovascular treatment of patients with abdominal aortic aneurysm or aortoiliac aneurysms having vascular anatomy suitable for endovascular repair. These indications are aligned with the terms of market authorization.

According to the company, the introduction system features an ergonomic design and requires fewer procedural steps than previous designs to deploy the device without sacrificing the precision and control of the Zenith platform. The device also allows for wider patient applicability because of its lower profile introduction system, three-piece modular design, and broad range of sizes.

In the Cook Medical announcement, Adam Power, MD, assistant professor and program director of vascular surgery at University of Western London Health Sciences Center commented, “We would like to thank Cook for the opportunity to place the first Cook Alpha AAA endograft in North America. We are proud of our aortic experience here at Western University and this case enables us to continue pushing innovative approaches to aortic pathology for the best treatment of our patients.”